Old Web
English
Sign In
Acemap
>
authorDetail
>
David Vigushin
David Vigushin
Charing Cross Hospital
Urine
Breast cancer
Medicine
Phases of clinical research
Pharmacology
3
Papers
232
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Interpretation Single-agent gefitinib and gefitinib combined with anastrozole are well-tolerated and effective treatments for reducing the size of breast tumours and levels of ER phosphorylation when given as neoadjuvant therapy. Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial
2005
Andreas Polychronis
H. Dudley Sinnett
Dimitri Hadjiminas
Hemant Singhal
Janine L. Mansi
Sami Shousha
Jie Jiang
David Peston
Nigel Barrett
David Vigushin
Ken Morrison
Emma Beresford
Simak Ali
Martin J. Slade
R. Charles Coombes
Show All
Source
Cite
Save
Citations (0)
Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer
1998
Cancer Chemotherapy and Pharmacology
David Vigushin
Grace K. Poon
Alan V. Boddy
Jacqueline English
Gavin Halbert
Christos Pagonis
Michael Jarman
R.Charles Coombes
Show All
Source
Cite
Save
Citations (181)
Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry.
1996
Drug Metabolism and Disposition
Grace K. Poon
David Vigushin
Leslie J. Griggs
Martin G. Rowlands
R. C. Coombes
Michael Jarman
Show All
Source
Cite
Save
Citations (51)
1